TO5. Clinical coordinating center for nida's clinical trials network. Contract type: IDIQ task order. POP: 8/15/24 - 8/14/29
Active Awarded Last action
- Contract number
- 75N95025F00002
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,501,452
Award facts
- Opportunity
-
- TORFP5 Solicitation number
- Contract value 100% obligated
- $2,501,452.23 Current and potential, with all options
- Completion date 47% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $793,954 | |
| Original award | $1,707,498 |
About this award
The National Institute on Drug Abuse issued a delivery order to The Emmes Company, LLC on July 16, 2025, with a ceiling value of $2,501,452.23, under the Clinical Coordinating Center for NIDA's Clinical Trials Network IDIQ, a single-award vehicle valued at $49.5 million with ceiling through August 14, 2029.
The order supports clinical coordinating center functions and multi-site clinical trials coordination for NIDA's substance abuse treatment research, including studies on opioid use disorder, stimulant use, cocaine use, and related conditions. Place of performance is Rockville, Maryland. The period of performance runs from August 15, 2024, through August 14, 2029, with an ultimate completion date of March 31, 2028. The order is priced on a cost-plus-fixed-fee basis.
In FY2025, this delivery order generated $66 thousand in government-invoiced labor against 0.2 FTEs, with self-performed delivery and no subcontractors reported.
Quick answers
Who was awarded contract 75N95025F00002?
75N95025F00002 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on July 16, 2025.
How much is contract 75N95025F00002 worth?
The government has obligated $2,501,452 on 75N95025F00002.
Is contract 75N95025F00002 an order under another contract?
Yes. 75N95025F00002 is a delivery order under 75N95024D00037, an indefinite delivery contract.
Was contract 75N95025F00002 competed?
The extent of competition for 75N95025F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award